Roche is set to acquire Carmot Therapeutics, along with three clinical-stage assets for treating obesity and diabetes, for a maximum of €2.85 billion. The agreement involves...
In markets we face risk constantly. Trying to figure out what the risks are and where we are in the cycle is the hard part. This...